BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7978801)

  • 1. Low molecular weight inhibitors in corneal ulceration.
    Galardy RE; Cassabonne ME; Giese C; Gilbert JH; Lapierre F; Lopez H; Schaefer ME; Stack R; Sullivan M; Summers B
    Ann N Y Acad Sci; 1994 Sep; 732():315-23. PubMed ID: 7978801
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of peptide-based matrix metalloproteinase inhibitors in corneal ulceration.
    Gray RD; Paterson CA
    Ann N Y Acad Sci; 1994 Sep; 732():206-16. PubMed ID: 7978792
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of a synthetic metalloproteinase inhibitor on corneal ulceration in alkali burns and pseudomonas keratitis.
    Burns FR; Gray RD; Wells JT; Paterson CA
    Matrix Suppl; 1992; 1():317-8. PubMed ID: 1480049
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor.
    Barletta JP; Angella G; Balch KC; Dimova HG; Stern GA; Moser MT; van Setten GB; Schultz GS
    Invest Ophthalmol Vis Sci; 1996 Jan; 37(1):20-8. PubMed ID: 8550324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a metalloproteinase inhibitor on established corneal ulcers after an alkali burn.
    Wentworth JS; Paterson CA; Gray RD
    Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2174-9. PubMed ID: 1607227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical ascorbate decreases the incidence of corneal ulceration after experimental alkali burns.
    Pfister RR; Paterson CA; Hayes SA
    Invest Ophthalmol Vis Sci; 1978 Oct; 17(10):1019-24. PubMed ID: 700951
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant tissue inhibitor of metalloproteinases type 1 suppresses alkali-burn-induced corneal ulceration in rabbits.
    Paterson CA; Wells JG; Koklitis PA; Higgs GA; Docherty AJ
    Invest Ophthalmol Vis Sci; 1994 Feb; 35(2):677-84. PubMed ID: 8113019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of alkali-injured rabbit corneas with a synthetic inhibitor of matrix metalloproteinases.
    Schultz GS; Strelow S; Stern GA; Chegini N; Grant MB; Galardy RE; Grobelny D; Rowsey JJ; Stonecipher K; Parmley V
    Invest Ophthalmol Vis Sci; 1992 Nov; 33(12):3325-31. PubMed ID: 1385350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase inhibitors reduce phorbol ester-induced cutaneous inflammation and hyperplasia.
    Holleran WM; Galardy RE; Gao WN; Levy D; Tang PC; Elias PM
    Arch Dermatol Res; 1997 Feb; 289(3):138-44. PubMed ID: 9128761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of alkali-induced corneal ulceration and perforation by a thiol peptide.
    Burns FR; Gray RD; Paterson CA
    Invest Ophthalmol Vis Sci; 1990 Jan; 31(1):107-14. PubMed ID: 2153643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of matrix metalloproteinase inhibitor on experimental pseudomonal corneal ulceration].
    Kosaku K; Maeda N; Yokoyama T; Inoue T; Yoshida Y; Hosokawa T; Sawa M
    Nippon Ganka Gakkai Zasshi; 1998 Nov; 102(11):717-23. PubMed ID: 9852715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaylsis of birefringence during wound healing and remodeling following alkali burns in rabbit cornea.
    Huang Y; Meek KM; Ho MW; Paterson CA
    Exp Eye Res; 2001 Oct; 73(4):521-32. PubMed ID: 11825023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of galardin on collagen degradation by Pseudomonas aeruginosa.
    Hao JL; Nagano T; Nakamura M; Kumagai N; Mishima H; Nishida T
    Exp Eye Res; 1999 Dec; 69(6):595-601. PubMed ID: 10620388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of stromal ulceration in the alkali-burned rabbit cornea by glued-on contact lens. Evidence for the role of polymorphonuclear leukocytes in collagen degradation.
    Kenyon KR; Berman M; Rose J; Gage J
    Invest Ophthalmol Vis Sci; 1979 Jun; 18(6):570-87. PubMed ID: 447459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific inhibitors of Pseudomonas aeruginosa elastase as potential drugs for the treatment of Pseudomonas keratitis.
    Kessler E; Blumberg S
    Antibiot Chemother (1971); 1987; 39():102-12. PubMed ID: 3118777
    [No Abstract]   [Full Text] [Related]  

  • 16. Matrix metalloproteinase inhibitors: a structure-activity study.
    Levy DE; Lapierre F; Liang W; Ye W; Lange CW; Li X; Grobelny D; Casabonne M; Tyrrell D; Holme K; Nadzan A; Galardy RE
    J Med Chem; 1998 Jan; 41(2):199-223. PubMed ID: 9457244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for TIMP-1 protection against P. aeruginosa-induced corneal ulceration and perforation.
    Kernacki KA; Barrett R; Hazlett LD
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3168-76. PubMed ID: 10586939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of corneal ulceration by tetrapeptidyl hydroxamic acid.
    Kigasawa K; Murata H; Morita Y; Odake S; Suda E; Shimizu I; Morikawa T; Nagai Y
    Jpn J Ophthalmol; 1995; 39(1):35-42. PubMed ID: 7643481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of metalloproteinase inhibitor on corneal cytokine expression after alkali injury.
    Sotozono C; He J; Tei M; Honma Y; Kinoshita S
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2430-4. PubMed ID: 10476814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkali-induced corneal stromal melting prevention by a novel platelet-activating factor receptor antagonist.
    He J; Bazan NG; Bazan HE
    Arch Ophthalmol; 2006 Jan; 124(1):70-8. PubMed ID: 16401787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.